| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Many peptide precursors encode more than one bioactive peptide. Recent cloning of the rat neuromedin U (NmU) precursor revealed potential proteolytic processing sites which may generate three associated peptides in addition to the NmU peptide, which is known to have potent uterine contractile effects. To assess the degree of evolutionary conservation, which often suggests conserved biological function and hence physiological importance, we have cloned and sequenced the cDNA encoding the human NmU precursor. Sequence analysis revealed a 174 amino acid human precursor containing the 25 residue NmU peptide near the C terminus of the precursor. The human message sequence was 74% homologous with that of the rat, indicating evolutionary conservation of the precursor between these two species. Four out of five of the putative proteolytic processing sites, first revealed in the rat precursor, were conserved in the human precursor, indicating a similar processing mechanism in both species. Two such processing sites flank a 33 residue peptide sequence which differed in only two amino acids compared with the rat homologue. This conservation suggests a possible biological role for this putative peptide.
Northern blot analysis of human gastrointestinal tissues revealed a similar level of mRNA throughout the gastrointestinal tract. RIA using a porcine specific assay showed the highest levels of peptide in the jejunum samples.
This article has been cited by other articles:
|
|
 |
|
  J. D. Mitchell, J. J. Maguire, R. E. Kuc, and A. P. Davenport Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system Cardiovasc Res, November 26, 2008; (2008) cvn302v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Hainerova, S. S. Torekov, J. Ek, M. Finkova, K. Borch-Johnsen, T. Jorgensen, O. D. Madsen, J. Lebl, T. Hansen, and O. Pedersen Association between Neuromedin U Gene Variants and Overweight and Obesity J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 5057 - 5063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Takahashi, C. Furukawa, A. Takano, N. Ishikawa, T. Kato, S. Hayama, C. Suzuki, W. Yasui, K. Inai, S. Sone, et al. The Neuromedin U-Growth Hormone Secretagogue Receptor 1b/Neurotensin Receptor 1 Oncogenic Signaling Pathway as a Therapeutic Target for Lung Cancer Cancer Res., October 1, 2006; 66(19): 9408 - 9419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T J Kowalski, B D Spar, L Markowitz, M Maguire, A Golovko, S Yang, C Farley, J A Cook, G Tetzloff, L Hoos, et al. Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice J. Endocrinol., April 1, 2005; 185(1): 151 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Brighton, P. G. Szekeres, and G. B. Willars Neuromedin U and Its Receptors: Structure, Function, and Physiological Roles Pharmacol. Rev., June 1, 2004; 56(2): 231 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Wren, C. J. Small, C. R. Abbott, P. H. Jethwa, A. R. Kennedy, K. G. Murphy, S. A. Stanley, A. N. Zollner, M. A. Ghatei, and S. R. Bloom Hypothalamic Actions of Neuromedin U Endocrinology, November 1, 2002; 143(11): 4227 - 4234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Westfall, G. P. McCafferty, M. Pullen, S. Gruver, A. C. Sulpizio, V. N. Aiyar, J. Disa, L. C. Contino, I. J. Mannan, and J. P. Hieble Characterization of Neuromedin U Effects in Canine Smooth Muscle J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 987 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Hedrick, K. Morse, L. Shan, X. Qiao, L. Pang, S. Wang, T. Laz, E. L. Gustafson, M. Bayne, and F. J. Monsma Jr. Identification of a Human Gastrointestinal Tract and Immune System Receptor for the Peptide Neuromedin U Mol. Pharmacol., October 1, 2000; 58(4): 870 - 875. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. L. Salmon, A. H. Johnsen, M. Bienert, G. McMurray, K. A. Nandha, S. R. Bloom, and C. Shaw Isolation, Structural Characterization, and Bioactivity of a Novel Neuromedin U Analog from the Defensive Skin Secretion of the Australasian Tree Frog, Litoria caerulea J. Biol. Chem., February 18, 2000; 275(7): 4549 - 4554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Szekeres, A. I. Muir, L. D. Spinage, J. E. Miller, S. I. Butler, A. Smith, G. I. Rennie, P. R. Murdock, L. R. Fitzgerald, H.-l. Wu, et al. Neuromedin U Is a Potent Agonist at the Orphan G Protein-coupled Receptor FM3 J. Biol. Chem., June 30, 2000; 275(27): 20247 - 20250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Shan, X. Qiao, J. H. Crona, J. Behan, S. Wang, T. Laz, M. Bayne, E. L. Gustafson, F. J. Monsma Jr., and J. A. Hedrick Identification of a Novel Neuromedin U Receptor Subtype Expressed in the Central Nervous System J. Biol. Chem., December 8, 2000; 275(50): 39482 - 39486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Fujii, M. Hosoya, S. Fukusumi, Y. Kawamata, Y. Habata, S. Hinuma, H. Onda, O. Nishimura, and M. Fujino Identification of Neuromedin U as the Cognate Ligand of the Orphan G Protein-coupled Receptor FM-3 J. Biol. Chem., July 7, 2000; 275(28): 21068 - 21074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hosoya, T. Moriya, Y. Kawamata, S. Ohkubo, R. Fujii, H. Matsui, Y. Shintani, S. Fukusumi, Y. Habata, S. Hinuma, et al. Identification and Functional Characterization of a Novel Subtype of Neuromedin U Receptor J. Biol. Chem., September 15, 2000; 275(38): 29528 - 29532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Raddatz, A. E. Wilson, R. Artymyshyn, J. A. Bonini, B. Borowsky, L. W. Boteju, S. Zhou, E. V. Kouranova, R. Nagorny, M. S. Guevarra, et al. Identification and Characterization of Two Neuromedin U Receptors Differentially Expressed in Peripheral Tissues and the Central Nervous System J. Biol. Chem., October 13, 2000; 275(42): 32452 - 32459. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
